Taiwan
· Delayed Price · Currency is TWD Lotus Pharmaceutical Statistics
Total Valuation
TPE:1795 has a market cap or net worth of TWD 59.51 billion. The enterprise value is 67.15 billion.
| Market Cap | 59.51B |
| Enterprise Value | 67.15B |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | Aug 5, 2024 |
Share Statistics
TPE:1795 has 262.16 million shares outstanding. The number of shares has increased by 0.51% in one year.
| Current Share Class | 262.16M |
| Shares Outstanding | 262.16M |
| Shares Change (YoY) | +0.51% |
| Shares Change (QoQ) | -0.92% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 6.83% |
| Float | 160.49M |
Valuation Ratios
The trailing PE ratio is 10.95 and the forward PE ratio is 10.76.
| PE Ratio | 10.95 |
| Forward PE | 10.76 |
| PS Ratio | 3.11 |
| PB Ratio | 2.81 |
| P/TBV Ratio | 6.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.29 |
| EV / Sales | 3.51 |
| EV / EBITDA | 8.51 |
| EV / EBIT | 10.11 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 1.73 |
| Debt / FCF | n/a |
| Interest Coverage | 11.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.04% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 17.39M |
| Profits Per Employee | 4.97M |
| Employee Count | 1,099 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.18% in the last 52 weeks. The beta is -0.01, so TPE:1795's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -19.18% |
| 50-Day Moving Average | 231.76 |
| 200-Day Moving Average | 260.89 |
| Relative Strength Index (RSI) | 51.31 |
| Average Volume (20 Days) | 1,298,392 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1795 had revenue of TWD 19.12 billion and earned 5.46 billion in profits. Earnings per share was 20.73.
| Revenue | 19.12B |
| Gross Profit | 11.54B |
| Operating Income | 6.64B |
| Pretax Income | 6.80B |
| Net Income | 5.46B |
| EBITDA | 7.80B |
| EBIT | 6.64B |
| Earnings Per Share (EPS) | 20.73 |
Balance Sheet
The company has 6.03 billion in cash and 13.67 billion in debt, giving a net cash position of -7.64 billion or -29.13 per share.
| Cash & Cash Equivalents | 6.03B |
| Total Debt | 13.67B |
| Net Cash | -7.64B |
| Net Cash Per Share | -29.13 |
| Equity (Book Value) | 21.18B |
| Book Value Per Share | 79.81 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 60.35%, with operating and profit margins of 34.74% and 28.59%.
| Gross Margin | 60.35% |
| Operating Margin | 34.74% |
| Pretax Margin | 35.55% |
| Profit Margin | 28.59% |
| EBITDA Margin | 40.78% |
| EBIT Margin | 34.74% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.73, which amounts to a dividend yield of 2.57%.
| Dividend Per Share | 5.73 |
| Dividend Yield | 2.57% |
| Dividend Growth (YoY) | 34.32% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | -0.51% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 9.18% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |